Imunon, Inc.

US$0.84As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMNNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (55.54%)
Div yield —
ROE (429.72%)
Biotechnology
Beta (5Y) 2.08
PE TTM —
TSR TTM (81.43%)
Mkt cap US$4.741M
ROIC (116.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.09
28.57%
176.47%
Hold 8|9|3|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
1.88%
(10.19%)
(0.89%)
(4.18%)
Revenue$M
0.467
0.488
0.499
0.495
15.66%
14.47%
17.33%
12.12%
Peers (US$4.741M)
Cap (US$)
PE
4.878M
—
Capital
TTM
5Y
10Y
Leveragex
0.125
0.101
0.104
EBIT/Intx
0.726
0.993
0.970
Own earn%
(169.64)
5.13
12.22
Sh yield%
36.41
20.16
19.79
Owners
Insiders/Inst%
8.25
35.73
Short interest%
3.24
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–5
$1 testx
0.1
Incr. ROIC%
10